base-metals-investing Lineage Takes Delivery of Gene-edited Hypoimmune Cell Line Under Partnership With Factor Bioscience
base-metals-investing Lineage Cell Therapeutics to Report Third Quarter 2025 Financial Results and Provide Business Update on November 6, 2025
base-metals-investing Lineage Announces Research Collaboration With William Demant Invest to Develop ReSonance for Hearing Loss
base-metals-investing Lineage Cell Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
base-metals-investing OpRegen® Phase 1/2a Clinical Study 24-Month Visual Acuity Results Featured at 2024 Retinal Cell & Gene Therapy Innovation Summit
base-metals-investing Lineage Cell Therapeutics to Report First Quarter 2024 Financial Results and Provide Business Update on May 9, 2024
base-metals-investing Lineage Cell Therapeutics to Report First Quarter 2024 Financial Results and Provide Business Update on May 9, 2024
Jura Announces Dismissal in Full of PEL's Appeal against certain reliefs granted in the Settlement Agreement Arbitral Award
U.S. Army Awards Salesforce $5.6B Contract to Accelerate Military Modernization and Department of War Readiness
American Pacific Mails Meeting Materials for Annual General and Special Meeting in Connection with Previously Announced Plan of Arrangement with ICG Silver & Gold Ltd.
